Antibodies are useful tools to characterize the compo-nents of the human proteome and to validate potential protein biomarkers discovered through various clinical proteomics efforts. The lack of validation results across various applications for most antibodies often makes it necessary to perform cumbersome investigations to en-sure specificity of a particular antibody in a certain appli-cation. A need therefore exists for a standardized sys-tem for sharing validation data about publicly available antibodies and to allow antibody providers as well as users to contribute and edit experimental evidence data, including data also on the antigen. Here we describe a new publicly available portal called Antibodypedia, which has been developed to a...
The advent of high-throughput proteomics has enabled the identification of ever increasing numbers o...
Bio-molecular reagents, like antibodies that are required in experimental biology are expensive and ...
There is a need for standardized validation methods for antibody specificity and selectivity. Recent...
Validation of antibodies and other protein binders is a subject of pressing concern for the research...
Humans are believed to have ~20,500 protein-coding genes andmuch effort has over the last years been...
The newly launched Affinity Binder Knockdown Initiative encourages antibody suppliers and users to j...
AbstractThe newly launched Affinity Binder Knockdown Initiative encourages antibody suppliers and us...
Clinical proteomics is an emerging field that deals with the use of proteomic technologies for medic...
<p>A slideset that discusses <em>F1000Research</em>'s Antibody Validation Collection. The collection...
Contains fulltext : 171662.pdf (Publisher’s version ) (Open Access)Antibodies are ...
In the wake of the reproducibility crisis and numerous discussions on how commercially available ant...
Protein affinity reagents (PARs), most commonly antibodies, are essential reagents for protein chara...
Protein affinity reagents (PARs), most commonly antibodies, are essential reagents for protein chara...
Protein affinity reagents (PARs), most commonly antibodies, are essential reagents for protein chara...
In the wake of the reproducibility crisis and numerous discussions on how commercially available ant...
The advent of high-throughput proteomics has enabled the identification of ever increasing numbers o...
Bio-molecular reagents, like antibodies that are required in experimental biology are expensive and ...
There is a need for standardized validation methods for antibody specificity and selectivity. Recent...
Validation of antibodies and other protein binders is a subject of pressing concern for the research...
Humans are believed to have ~20,500 protein-coding genes andmuch effort has over the last years been...
The newly launched Affinity Binder Knockdown Initiative encourages antibody suppliers and users to j...
AbstractThe newly launched Affinity Binder Knockdown Initiative encourages antibody suppliers and us...
Clinical proteomics is an emerging field that deals with the use of proteomic technologies for medic...
<p>A slideset that discusses <em>F1000Research</em>'s Antibody Validation Collection. The collection...
Contains fulltext : 171662.pdf (Publisher’s version ) (Open Access)Antibodies are ...
In the wake of the reproducibility crisis and numerous discussions on how commercially available ant...
Protein affinity reagents (PARs), most commonly antibodies, are essential reagents for protein chara...
Protein affinity reagents (PARs), most commonly antibodies, are essential reagents for protein chara...
Protein affinity reagents (PARs), most commonly antibodies, are essential reagents for protein chara...
In the wake of the reproducibility crisis and numerous discussions on how commercially available ant...
The advent of high-throughput proteomics has enabled the identification of ever increasing numbers o...
Bio-molecular reagents, like antibodies that are required in experimental biology are expensive and ...
There is a need for standardized validation methods for antibody specificity and selectivity. Recent...